Published in Antimicrob Agents Chemother on June 01, 1997
Current status of antimicrobial resistance in Taiwan. Emerg Infect Dis (2002) 1.55
Genetic-biochemical analysis and distribution of the Ambler class A beta-lactamase CME-2, responsible for extended-spectrum cephalosporin resistance in Chryseobacterium (Flavobacterium) meningosepticum. Antimicrob Agents Chemother (2000) 1.46
Clinical and microbiological analysis of bloodstream infections caused by Chryseobacterium meningosepticum in nonneonatal patients. J Clin Microbiol (2004) 1.23
Elizabethkingia meningoseptica: Emerging nosocomial pathogen in bedside hemodialysis patients. Indian J Crit Care Med (2013) 0.99
Chryseobacterium indologenes peritonitis in a patient with malignant ascites. Int Med Case Rep J (2011) 0.85
Catheter-related Chryseobacterium meningosepticum bacteraemia in a haemodialysis patient. NDT Plus (2009) 0.84
Susceptibilities of Chryseobacterium indologenes and Chryseobacterium meningosepticum to cefepime and cefpirome. J Clin Microbiol (1997) 0.83
MYROIDES INFECTION IN A BABOON AFTER PROLONGED PIG KIDNEY GRAFT SURVIVAL. Transplant Direct (2015) 0.82
Bacteremia due to Elizabethkingia meningoseptica. IDCases (2015) 0.80
Antibacterial activities of multi drug resistant Myroides odoratimimus bacteria isolated from adult flesh flies (Diptera: sarcophagidae) are independent of metallo beta-lactamase gene. Braz J Microbiol (2008) 0.75
Uses of 2-ethoxy-4(3H) quinazolinone in synthesis of quinazoline and quinazolinone derivatives of antimicrobial activity: the solvent effect. Glob J Health Sci (2011) 0.75
Chryseobacterium indologenes, a possible emergent organism resistant to carbapenem antimicrobials after stem cell transplantation. Clin Case Rep (2016) 0.75
Susceptibility tests of anaerobic bacteria: statistical and clinical considerations. J Infect Dis (1974) 9.38
In vitro susceptibilities of nonfermentative gram-negative bacilli other than Pseudomonas aeruginosa to 32 antimicrobial agents. Rev Infect Dis (1981) 3.32
Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol (1996) 2.19
Activities of aztreonam and new cephalosporins against infrequently isolated gram-negative bacilli. Antimicrob Agents Chemother (1983) 2.11
Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis (1996) 1.77
Subacute bacterial endocarditis due to Flavobacterium meningosepticum. Am J Clin Pathol (1972) 1.61
Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother (1995) 1.61
Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by Flavobacterium Species. N Engl J Med (1975) 1.59
Antimicrobial susceptibility of flavobacteria. Antimicrob Agents Chemother (1978) 1.44
Vancomycin therapy of bacterial meningitis. Am J Dis Child (1973) 1.43
Epidemic meningitis of the newborn caused by flavobacteria. II. Clinical manifestations and treatment. Am J Dis Child (1961) 1.37
Flavobacterium meningosepticum infection: an epidemiological study in a newborn nursery. J Clin Pathol (1981) 1.30
Comparative in-vitro activity of ciprofloxacin against non-fermenters. J Antimicrob Chemother (1985) 1.28
Use of a predictor panel for development of a new disk for diffusion tests with cefoperazone-sulbactam. Antimicrob Agents Chemother (1992) 1.26
Flavobacterium meningosepticum meningitis in a newborn infant. Treatment with intraventricular erythromycin. J Pediatr (1974) 1.22
In-vitro sensitivity of Elavobacterium meningosepticum to antimicrobial agents. J Med Microbiol (1971) 1.20
Flavobacterium group IIb bacteremia: report of a case and review of Flavobacterium infections. Med Microbiol Immunol (1987) 1.20
In vitro antimicrobial activity of ceftizoxime against glucose-nonfermentative gram-negative rods. Antimicrob Agents Chemother (1981) 1.14
Bacteremic necrotizing fasciitis due to Flavobacterium odoratum. Clin Infect Dis (1995) 1.11
Activity of meropenem against antibiotic-resistant or infrequently encountered gram-negative bacilli. Antimicrob Agents Chemother (1991) 1.09
Flavobacterium meningosepticum. Infect Control (1984) 1.07
Rifamycin in neonatal flavobacteria meningitis. Arch Dis Child (1976) 1.06
Flavobacterium meningosepticum meningitis in an adult. Am J Med (1988) 1.03
Pyomyositis in intravenous drug abusers: report of a unique case and review of the literature. Clin Infect Dis (1996) 0.94
Flavobacterial sepsis in massively burned pediatric patients. Clin Infect Dis (1993) 0.93
Antimicrobial susceptibility of Flavobacterium meningosepticum strains identified by DNA-DNA hybridization. Acta Pathol Microbiol Immunol Scand B (1987) 0.90
Oral ciprofloxacin therapy of infection caused by multiply resistant bacteria other than Pseudomonas aeruginosa. J Antimicrob Chemother (1986) 0.88
Fatal pneumonia caused by Flavobacterium meningosepticum. Pediatr Infect Dis J (1989) 0.84
Flavobacterium meningosepticum keratitis successfully treated with topical trimethoprim-sulfamethoxazole. Am J Ophthalmol (1991) 0.84
Community-acquired Flavobacterium meningosepticum meningitis, pneumonia and septicemia in a normal infant. Pediatr Infect Dis J (1991) 0.78
Metallo-beta-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob Agents Chemother (2001) 4.72
Prevalence of SHV-12 among clinical isolates of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and identification of a novel AmpC enzyme (CMY-8) in Southern Taiwan. Antimicrob Agents Chemother (2000) 2.96
Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother (1985) 2.66
Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature (1995) 2.48
Severe community-acquired pneumonia due to Acinetobacter baumannii. Chest (2001) 2.46
Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int J Tuberc Lung Dis (2000) 2.29
Identification of a plasmid encoding SHV-12, TEM-1, and a variant of IMP-2 metallo-beta-lactamase, IMP-8, from a clinical isolate of Klebsiella pneumoniae. Antimicrob Agents Chemother (2001) 2.21
Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol (1996) 2.19
Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol (2000) 2.11
High incidence of erythromycin-resistant streptococci in Taiwan. Antimicrob Agents Chemother (1997) 1.97
Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells (1991) 1.95
Outbreak of infection with multidrug-resistant Klebsiella pneumoniae carrying bla(IMP-8) in a university medical center in Taiwan. J Clin Microbiol (2001) 1.88
Role of streptococcal pyrogenic exotoxin B in the mouse model of group A streptococcal infection. Infect Immun (1998) 1.84
Fungal empyema thoracis: an emerging clinical entity. Chest (2000) 1.80
Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis. J Antimicrob Chemother (1998) 1.80
Bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a pediatric oncology ward: clinical features and identification of different plasmids carrying both SHV-5 and TEM-1 genes. J Clin Microbiol (1999) 1.77
Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis (1996) 1.77
Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis (1997) 1.75
PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys. Kidney Int (2007) 1.73
Severe immune hemolytic anemia in disseminated tuberculosis with response to antituberculosis therapy. Chest (2001) 1.73
Collagen type IX: evidence for covalent linkages to type II collagen in cartilage. FEBS Lett (1987) 1.69
Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan. Clin Microbiol Infect (2005) 1.67
Klebsiella pneumoniae isolates causing liver abscess in Taiwan. Diagn Microbiol Infect Dis (2000) 1.65
Control of the initiation of sporulation in Bacillus subtilis by a phosphorelay. Res Microbiol (1992) 1.64
Cryptococcal meningitis in non-HIV-infected patients. QJM (2000) 1.63
Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob Agents Chemother (1995) 1.61
Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia. J Infect (2000) 1.61
Tuberculous myositis: a rare but existing clinical entity. Rheumatology (Oxford) (2003) 1.61
Staphylococcus aureus meningitis in adults: a clinical comparison of infections caused by methicillin-resistant and methicillin-sensitive strains. Infection (2001) 1.60
Bacteremia caused by Arcobacter cryaerophilus 1B. J Clin Microbiol (1997) 1.59
Serodiagnosis of tuberculosis. A study comparing three specific mycobacterial antigens. Am J Respir Crit Care Med (1997) 1.55
Melioidosis: an emerging infection in Taiwan? Emerg Infect Dis (2001) 1.55
Effect of group A streptococcal cysteine protease on invasion of epithelial cells. Infect Immun (1998) 1.54
Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection. Clin Exp Dermatol (2009) 1.53
Changes in cartilage composition and physical properties due to stromelysin degradation. Arthritis Rheum (1995) 1.52
Persistence of a multidrug-resistant Pseudomonas aeruginosa clone in an intensive care burn unit. J Clin Microbiol (1998) 1.52
Clinical and microbiological characteristics of bacteremia caused by Acinetobacter lwoffii. Eur J Clin Microbiol Infect Dis (2000) 1.51
Actinobacillus actinomycetemcomitans pneumonia with chest wall involvement and rib destruction. Chest (1992) 1.50
Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J Clin Oncol (2001) 1.50
Needle aspiration biopsy of malignant lung masses with necrotic centers. Improved sensitivity with ultrasonic guidance. Chest (1993) 1.48
Factors changing the manifestation of pulmonary tuberculosis. Int J Tuberc Lung Dis (2005) 1.46
Mutational dissociation of the positive and negative regulatory properties of the Spo0A sporulation transcription factor of Bacillus subtilis. Gene (1991) 1.44
Extremely high incidence of macrolide and trimethoprim-sulfamethoxazole resistance among clinical isolates of Streptococcus pneumoniae in Taiwan. J Clin Microbiol (1999) 1.44
A positive feedback loop controls transcription of the spoOF gene, a component of the sporulation phosphorelay in Bacillus subtilis. Mol Microbiol (1993) 1.42
Klebsiella pneumoniae meningitis: timing of antimicrobial therapy and prognosis. QJM (2000) 1.40
Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer. Am J Respir Crit Care Med (2000) 1.39
Secular trends in the epidemiology of nosocomial fungal infections at a teaching hospital in Taiwan, 1981 to 1993. Infect Control Hosp Epidemiol (1997) 1.38
Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J Clin Microbiol (1998) 1.37
High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother (2001) 1.36
Diagnostic performance of an enzyme-linked immunospot assay for interferon-gamma in extrapulmonary tuberculosis varies between different sites of disease. J Infect (2009) 1.35
Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol (1999) 1.34
Value of sonography in determining the nature of pleural effusion: analysis of 320 cases. AJR Am J Roentgenol (1992) 1.34
Erythrocyte sedimentation rate and C-reactive protein values in patients with total hip arthroplasty. Clin Orthop Relat Res (1987) 1.34
Catalytic growth and characterization of gallium nitride nanowires. J Am Chem Soc (2001) 1.33
Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption. A case report and review of literature. Br J Dermatol (2001) 1.33
Catheter-related bacteraemia and infective endocarditis caused by Kocuria species. Clin Microbiol Infect (2011) 1.32
Evaluation of ultrasonically guided biopsies of mediastinal masses. Chest (1991) 1.28
Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997-2003. Epidemiol Infect (2006) 1.27
Recurrent bacteremic peritonitis caused by Enterococcus cecorum in a patient with liver cirrhosis. J Clin Microbiol (2000) 1.27
Empyema thoracis and lung abscess caused by viridans streptococci. Am J Respir Crit Care Med (1997) 1.26
Arcobacter butzleri bacteremia in a patient with liver cirrhosis. J Formos Med Assoc (2000) 1.26
Collagen of fibrocartilage: a distinctive molecular phenotype in bovine meniscus. FEBS Lett (1983) 1.26
Antimicrobial resistance and serotype distribution of Streptococcus pneumoniae strains isolated in southern Taiwan. J Formos Med Assoc (1996) 1.25
Infections caused by Gordonia species at a medical centre in Taiwan, 1997 to 2008. Clin Microbiol Infect (2010) 1.25
Molecular evidence for strain dissemination of Penicillium marneffei: an emerging pathogen in Taiwan. J Infect Dis (2000) 1.25
Pulmonary fungal infection: emphasis on microbiological spectra, patient outcome, and prognostic factors. Chest (2001) 1.25
Septic shock due to Helicobacter fennelliae in a non-human immunodeficiency virus-infected heterosexual patient. J Clin Microbiol (1999) 1.24
A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest (2000) 1.23